CME
Cme Group Inc.Company with tickers: CME
CIK
1156375
CUSIP
12572Q105
Shares Outstanding
66,643,583
Investor Relations
https://www.cmegroup.com/investor-relations.html
13F Activity (30d)
66 filings
21 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$3,000,000,000
as of 2025-12-31
Remaining Authorization
$2,200,000,000
as of 2026-03-31
Program Utilization
26.7%
$800,000,000 used of $3,000,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2013-12-31 | $0 | 10-K, filed 2014-03-03 |
| 2012-12-31 | $0 | 10-K, filed 2014-03-03 |
| 2011-12-31 | $220,400,000 | 10-K, filed 2014-03-03 |
| 2010-12-31 | $575,300,000 | 10-K, filed 2013-03-01 |
| 2009-12-31 | $27,000,000 | 10-K, filed 2012-02-28 |
| 2008-12-31 | $224,000,000 | 10-K, filed 2011-02-28 |
| 2007-12-31 | $949,300,000 | 10-K, filed 2010-02-26 |